Live Breaking News & Updates on Active Lupus

Stay updated with breaking news from Active lupus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aurinia Presents Breadth of Data from AURORA Clinical Program Underscoring Value of LUPKYNISⓇ (voclosporin) for Patients with Lupus Nephritis at ACR 2023

Aurinia Presents Breadth of Data from AURORA Clinical Program Underscoring Value of LUPKYNISⓇ (voclosporin) for Patients with Lupus Nephritis at ACR 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , San Francisco , San Diego , Ernie Yap , Samir Parikh , Matt Baker , Lucy Hodge , Bo Wen , Henry Leher , Matt Truman , Gabriel Contreras , Robertb Huizinga , Kory Engelke , Christopher Collins , Krishani Kumari Rajanayake , Salem Almaani , Estela Puchulu Campanella , Emily Littlejohn , Clint Abner , Ankhbayar Lkhagva , Maria Dallera , Arnon Arazi , Andrea Christopher , Duxin Sun , Neil Solomons , Jennifer Cross ,

Aurinia Presents Breadth of Data from AURORA Clinical Program Underscoring Value of LUPKYNISⓇ (voclosporin) for Patients with Lupus Nephritis at ACR 2023

Aurinia Presents Breadth of Data from AURORA Clinical Program Underscoring Value of LUPKYNISⓇ (voclosporin) for Patients with Lupus Nephritis at ACR 2023
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , San Diego , San Francisco , Matt Truman , Vanessa Birardi , Kory Engelke , Emily Littlejohn , Estela Puchulu Campanella , Duxin Sun , Christopher Collins , Gabriel Contreras , Matt Baker , Ankhbayar Lkhagva , Arnon Arazi , Krishani Kumari Rajanayake , Simon Zhou , Neil Solomons , Samir Parikh , Robertb Huizinga , Krista Piper , Maria Dallera , Greg Keenan , Pearlly Yan , Lucy Hodge , Bo Wen , Henry Leher ,

Aurinia Presents Data Demonstrating LUPKYNIS® (voclosporin) is Effective in Achieving Proteinuria Treatment Targets in Lupus Nephritis Defined by EULAR/ERA Recommendations

Aurinia Presents Data Demonstrating LUPKYNIS® (voclosporin) is Effective in Achieving Proteinuria Treatment Targets in Lupus Nephritis Defined by EULAR/ERA Recommendations
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Neil Solomons , Hans Joachim Anders , Dana Lynch , European Congress , Aurinia Pharmaceuticals Inc , American College Of Rheumatology , European Alliance Of Associations , University Of Munich , Corporate Communications , Aurinia Pharmaceuticals , European Renal Association , European Alliance , Chief Medical Officer , American College , Aurinia Urinary , Active Lupus , British Columbia , Red Cell Aplasia , Drug Interactions , Moderate Hepatic Impairment , Prescribing Information , Boxed Warning , Medication Guide ,

Aurinia Presents Results from the Two-Year AURORA 2 Continuation Study at the 2022 European Renal Association (ERA) Congress

Press release content from Business Wire. The AP news staff was not involved in its creation. ....

United States , United Kingdom , France General , Neil Solomons , Anca Askanase , Yk Onno Teng , Dana Lynch , Aurinia Pharmaceuticals Inc , Columbia University Medical Center , American College Of Rheumatology , Leiden University Medical Center , Corporate Communications , Aurinia Pharmaceuticals , European Renal Association , Chief Medical Officer , American College , Aurinia Urinary , Active Lupus , British Columbia , Red Cell Aplasia , Drug Interactions , Moderate Hepatic Impairment , Prescribing Information , Boxed Warning , Medication Guide , Business Wire ,

Aurinia Pharmaceuticals Inc.: Aurinia Presents Results from the Two-Year AURORA 2 Continuation Study at the 2022 European Renal Association (ERA) Congress

Use of LUPKYNIS was safe and well tolerated in patients for up to three years of treatment, with no new safety signals In AURORA 2, long-term treatment with LUPKYNIS led to a clinically relevant ....

United States , United Kingdom , France General , Neil Solomons , Anca Askanase , Yk Onno Teng , Dana Lynch , Aurinia Pharmaceuticals Inc , Columbia University Medical Center , American College Of Rheumatology , Leiden University Medical Center , Corporate Communications , Aurinia Pharmaceuticals , European Renal Association , Chief Medical Officer , American College , Aurinia Urinary , Active Lupus , British Columbia , Red Cell Aplasia , Drug Interactions , Moderate Hepatic Impairment , Prescribing Information , Boxed Warning , Medication Guide ,